
John Marshall, MD - Re-Invigorating the Later-Line Treatment of Metastatic Colorectal Cancer: Practical Strategies to Optimize the Use of Tyrosine Kinase Inhibitors
Please visit answersincme.com/KTK860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gastrointestinal cancers discusses strategies for treatment of patients with colorectal cancer using tyrosine kinase inhibitors. Upon completion of this activity, participants should be better able to: Identify patients with metastatic colorectal cancer (mCRC) who are suitable for tyrosine kinase inhibitor (TKI) treatment; Outline practical, patient-centered strategies to maximize quality of life in patients receiving later-line TKI treatment for mCRC; and Review approaches to manage adverse events associated with later-line TKI treatment for mCRC.
Publisher
CME in Minutes: Education in Gastroenterology
Link
answersincme.com/KTK860
Published
July 18, 2025
Duration
23 min
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Answers in CME
CME in Minutes: Education in Gastroenterology
@cmeinminuteseducationingastr
#metastaticcolorectalcancer #practicalstrategies #tyrosinekinaseinhibitors #lifesciences #medicine
